Quantcast

Latest Pulmonology Stories

2014-04-01 15:07:51

Clinical investigators at the Children’s Hospital of Eastern Ontario (CHEO) have developed a new screening tool to help diagnose obstructive sleep apnea in children. Their findings are published in Pediatric Pulmonology. Evidence suggests that adults with a large neck circumference are more likely to develop obstructive sleep apnea (OSA), especially males. As neck circumference varies by age and sex, there have been no reference ranges to diagnose pediatric OSA up until now. The new...

2014-04-01 08:27:28

LONDON, April 1, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:Inhalation & Nasal Spray Generic Drugs 2013 Around three quarters of the US$36.4 billion respiratory prescription drugs market comprises drugs that are delivered using inhalation or nasal spray technologies. The top five drugs used in the treatment of asthma and chronic obstructive pulmonary disease (COPD) attracted combined revenues of around US$18.0 billion in 2012. All five are...

2014-03-28 12:22:00

DUBLIN, Mar. 28, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/8gxjqj/investigation ) has announced the addition of the "Investigation Report on China's Tiotropium Bromide Market, 2009-2018" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) As the air becomes more contaminated, incidence of asthma and chronic obstructive pulmonary diseases also increases. Consequently, more market space is provided for relevant drug...

2014-03-20 23:29:32

Allergy season is in full swing and many of us are wheezing. The Pulmonica pulmonary harmonica helps loosen congestion to clear lungs and make breathing easier and this seminar will give practical information to improve your breathing. Sarasota, FL (PRWEB) March 20, 2014 Sarasota area residents who want to improve their breathing should circle March 25, 2014 on their calendar. Dana Keller, PhD, and his wife, Mary Lou, owners of Harmonica Techs, will lead a free Breathe Better Now seminar...

2014-03-18 12:31:32

CLEVELAND, March 18, 2014 /PRNewswire/ -- Simbionix, a world leader in medical simulation, and the American College of Chest Physicians (CHEST), a leader in advanced simulation education, enter the second phase of their collaboration to promote bronchoscopy education. The BRONCH Express, a virtual reality simulator for EBUS-TBNA training that is being co-developed by the organizations, will be featured at CHEST World Congress 2014. (Logo:...

2014-03-14 23:01:11

Program is one of only 15 nationwide to offer innovative, minimally invasive treatment options for complex pulmonary diseases. Mountain View, Calif. (PRWEB) March 14, 2014 El Camino Hospital and Palo Alto Medical Foundation are collaborating with the University of California, San Francisco (UCSF) Fellowship Program to be the first West Coast sites to offer interventional pulmonology fellowships for pulmonary fellows. Interventional pulmonology (IP) is an emerging field within pulmonary...

2014-03-13 23:27:32

This unique program will bring together key stakeholders who have a shared goal of balancing the treatment and management of patients with Chronic Obstructive Pulmonary Disease (COPD). San Diego, CA (PRWEB) March 13, 2014 The Pulmonary Horizons (PH) Conference Program Committee is pleased to announce that Thomas Kallstrom, MBA, RRT, FAARC, Executive Director and CEO of the American Association for Respiratory Care (AARC) will be delivering the keynote address at the conference. The PH...

2014-03-13 08:28:38

Conference Call Today, March 13, 2014 at 10:00 a.m. ET WARRINGTON, Pa., March 13, 2014 /PRNewswire/ -- Discovery Laboratories, Inc. (Nasdaq: DSCO), a specialty biotechnology company dedicated to advancing a new standard in respiratory critical care, today announced financial results for the fourth quarter ended December 31, 2013, as well as recent business updates. The Company will host a conference call today, March 13, 2014 at 10:00 AM ET. Conference call details are below. Key highlights...

2014-03-10 08:22:19

-- Bayer's Adempas (riociguat tablets) approved for the treatment of pulmonary arterial hypertension (PAH)(1), which affects up to 2000 Canadians(2) -- Adempas provides novel and specific approach to treat different types of pulmonary hypertension (PH), a serious condition of the heart and lungs -- Only drug in Canada indicated to treat two rare types of PH - PAH and chronic thromboembolic pulmonary hypertension (CTEPH)(1,3) TORONTO, March...

2014-03-05 08:25:34

National Campaign Seeks to Educate People with Asthma on the Importance of 'Knowing Their Count' LANDOVER, Md., March 5, 2014 /PRNewswire/ -- The Asthma and Allergy Foundation of America (AAFA) and Teva Respiratory announced today the launch of a national awareness campaign - Know Your Count - aimed at raising awareness of the seriousness of asthma and educating asthma patients and caregivers about the importance of keeping track of the remaining doses in their rescue inhalers. The...


Latest Pulmonology Reference Libraries

0_f9fe10c6664d20ba0d9091907b66a65f
2011-01-05 16:00:36

Human parainfluenza viruses, belonging to the paramyxovirus family, are a group of four distinct serotypes of enveloped single-stranded RNA viruses. They are the second most common cause of lower respiratory tract infection in younger children. Many times the host has repeat infections throughout life with symptoms that may include upper respiratory tract illness or more commonly, a cold and sore throat. It can also cause severe pneumonia in immunosuppressed people. There is currently no...

More Articles (1 articles) »
Word of the Day
attercop
  • A spider.
  • Figuratively, a peevish, testy, ill-natured person.
'Attercop' comes from the Old English 'atorcoppe,' where 'atter' means 'poison, venom' and‎ 'cop' means 'spider.' 'Coppa' is a derivative of 'cop,' top, summit, round head, or 'copp,' cup, vessel, which refers to 'the supposed venomous properties of spiders,' says the OED. 'Copp' is still found in the word 'cobweb.'
Related